Study on the possibility of insulin as a carrier of IUdR for hepatocellular carcinoma-targeted therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

327

HTML

2026

Figures (1-4)

188

Tables (1-2)

161

Sum=2702

Aug 15, 2003 (publication date) through Aug 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Aug 15, 2003; 9(8): 1675-1678
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1675

Full Size Figure Download Figure

Figure 2 Saturation binding curves of ¹²⁵I-insulin in hepatocel-lular carcinoma and its adjacent tissue.

Citation: Ou XH, Kuang AR, Peng X, Zhong YG. Study on the possibility of insulin as a carrier of IUdR for hepatocellular carcinoma-targeted therapy. World J Gastroenterol 2003; 9(8): 1675-1678
URL: https://www.wjgnet.com/1007-9327/full/v9/i8/1675.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i8.1675